...
首页> 外文期刊>American Journal of PharmTech Research >Formulation and Evaluation of Controlled Release Floating Tablet of Perindopril Erbumine using Natural Polymer
【24h】

Formulation and Evaluation of Controlled Release Floating Tablet of Perindopril Erbumine using Natural Polymer

机译:天然聚合物培哚普利氯丁胺控释浮片的研制与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

  ABSTRACT Floating dosage form for gastric retention has potential to use as controlled-release drug delivery systems which providing opportunity for both local and systemic drug action. The present work was aimed to formulate controlled release floating tablet (CRFT) of Perindopril Erbumine using gas generated low density approach. To develop CRFT, the Perindopril Erbumine was selected as a drug because it complies with the suitability criteria for the floating drug delivery system and the controlled release medication was required due to its potent action and poor bioavailability. The present investigation was suggested that the bioavailability of Perindopril Erbumine was improved due to increased gastric retention time and controlling the drug release rate using the natural polymer SFG, HPMCK15M and Acrypol 934. The CRFT of Perindopril Erbumine was developed by using wet granulation method and PVP K 30 was used as a granulating agent. The study was given the assurance that SFG had an excellent controlled drug releasing property then HPMCK15M by forming matrix in the formulation. The Acrypol 934 was added to control the drug release rate in to formulation and found good compressibility and controllable drug releasing properties in to the final formulation. All the formulation was evaluated for Weight variation, Thickness, Hardness, Diameter, Friability, Assay, FLT, TFT, Swelling Index and Dissolution study. Key Word: CRFT, SFG, Acrypol 934, FLT, TFT, SWI, Perindopril Erbumine, DSC
机译:摘要用于胃retention留的漂浮剂型有潜力用作控释药物输送系统,为局部和全身性药物作用提供机会。目前的工作旨在使用气体产生的低密度方法来配制培哚普利Erbumine的控释漂浮片剂(CRFT)。为了开发CRFT,选择Perindopril Erbumine作为药物,因为它符合浮动药物输送系统的适用性标准,并且由于其有效的作用和不良的生物利用度,因此需要控释药物。本研究表明,由于使用天然聚合物SFG,HPMCK15M和Acrypol 934可以增加胃保留时间并控制药物释放速率,从而提高了培哚普利Erbumine的生物利用率。 K 30用作造粒剂。通过确保制剂中形成基质,SFG具有比HPMCK15M更好的受控药物释放性能。加入Acrypol 934是为了控制制剂中的药物释放速率,并发现最终制剂中具有良好的可压缩性和可控的药物释放特性。评价所有配方的重量变化,厚度,硬度,直径,脆性,含量,FLT,TFT,溶胀指数和溶出度研究。关键字:CRFT,SFG,Acrypol 934,FLT,TFT,SWI,培哚普利Erbumine,DSC

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号